Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Amicus Therapeutics Inc shares valued at $80,100 were purchased by BRADLEY CAMPBELL on Oct 01 ’24. At $10.68 per share, BRADLEY CAMPBELL acquired 7,500 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Campbell Bradley L sold 7,500 shares, netting a total of over 87,798 in proceeds. Following the sale of shares at $11.71 each, the insider now holds 886,654 shares.
Before that, BRADLEY CAMPBELL had added 7,500 shares to its account. In a trade valued at $87,075, the Director bought Amicus Therapeutics Inc shares for $11.61 each.
As published in their initiating research note from Jefferies on September 06, 2024, Amicus Therapeutics Inc [FOLD] has been a Buy and the price target has been revised to $18. Analysts at Wells Fargo started covering the stock with ‘”an Overweight”‘ outlook in a report released in late May. As of May 14, 2024, Guggenheim has increased its “Neutral” rating to a “Buy” for FOLD. Earlier on December 19, 2023, Morgan Stanley upgraded its rating. Their new recommendation was “an Overweight” for FOLD stock which previously was a “an Equal-weight”.
Analyzing FOLD Stock Performance
During the last five days, there has been a drop of approximately -2.67%. Over the course of the year, Amicus Therapeutics Inc shares have dropped approximately -25.37%. Shares of the company reached a 52-week high of $14.53 on 01/02/24 and a 52-week low of $9.02 on 05/13/24. A 50-day SMA is recorded $11.07, while a 200-day SMA reached $11.40. Nevertheless, trading volume fell to 2.07 million shares from 2.24 million shares the previous day.
Support And Resistance Levels for Amicus Therapeutics Inc (FOLD)
According to the 24-hour chart, there is a support level at 10.49, which, if violated, would cause prices to drop to 10.40. In the upper region, resistance lies at 10.67. The next price resistance is at 10.75. RSI (Relative Strength Index) is 36.40 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.32, which suggests the price will decrease in the coming days. Percent R is at 84.69%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
